Strata Skin Scien (SSKN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,531 | -3,467 | -3,368 | -10,830 | -7,036 |
| Depreciation Amortization | 4,102 | 2,743 | 1,375 | 6,042 | 4,643 |
| Income taxes - deferred | N/A | N/A | N/A | -120 | N/A |
| Accounts receivable | 37 | 431 | 726 | 141 | -126 |
| Other Working Capital | 474 | 46 | 839 | -69 | -1,270 |
| Other Operating Activity | 403 | 34 | -376 | 4,317 | 1,899 |
| Operating Cash Flow | $-515 | $-213 | $-804 | $-519 | $-1,890 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,132 | -1,070 | -725 | -5,019 | -3,301 |
| Investing Cash Flow | $-1,132 | $-1,070 | $-725 | $-5,019 | $-3,301 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 7,000 | 7,000 |
| Common Stock Issued | 1,943 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -18 | -18 | -18 | -139 | -139 |
| Financing Cash Flow | $1,925 | $-18 | $-18 | $6,861 | $6,861 |
| Beginning Cash Position | 8,118 | 8,118 | 8,118 | 6,795 | 6,795 |
| End Cash Position | 8,396 | 6,817 | 6,571 | 8,118 | 8,465 |
| Net Cash Flow | $278 | $-1,301 | $-1,547 | $1,323 | $1,670 |
| Free Cash Flow | |||||
| Operating Cash Flow | -515 | -213 | -804 | -519 | -1,890 |
| Capital Expenditure | -1,132 | -1,070 | -725 | -5,019 | -3,301 |
| Free Cash Flow | -1,647 | -1,283 | -1,529 | -5,538 | -5,191 |